NCT04375696 - Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions

Weight Loss

Interventions

DRUG

Polyglucosamine L112

Polyglucosamine; Ascorbic Acid; Tartaric Acid

OTHER

Placebo

Dicalcium Phosphate; Microcrystalline Cellulose; Iron Oxide (yellow, brown, and black); Magnesium Stearate; Silicon Dioxide

Trial Locations (1)

Azienda di Servizi alla Persona Istituzioni Assistenziali Riunite di Pavia, Pavia